Changyan Yu
Impact in
- Aging top 2%
- Genetics, Aging, and Longevity in Model Organisms
Papers in
- Aging 12
- Genetics, Aging, and Longevity in Model Organisms 12
-
- Genomics, phytochemicals, and oxidative stress 2
- Natural product bioactivities and synthesis 2
- Epigenetics and DNA Methylation 2
- Co-authors
- Yi Xiao (18 shared papers)Sanhua Li (18 shared papers)Yun Liu (18 shared papers)Nian Jiang (18 shared papers)Xinting Zhu (15 shared papers)Fang Liu (10 shared papers)Changwei Song (5 shared papers)Lingjie Meng (8 shared papers)
- Journals
- International Immunopharmacology (4 papers)iScience (3 papers)European Journal of Pharmacology (2 papers)Infection and Immunity (1 paper)Reproductive Health (1 paper)
- Partner nations
- China
In The Last Decade
Changyan Yu
25 papers receiving 359 citations
Peers
Comparison fields: 5 of 72
- Aging 122
- Geriatrics and Gerontology 15
- Endocrine and Autonomic Systems 25
- Complementary and alternative medicine 28
- Cell Biology 56
Countries citing papers authored by Changyan Yu
This map shows the geographic impact of Changyan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changyan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changyan Yu more than expected).
Fields of papers citing papers by Changyan Yu
This network shows the impact of papers produced by Changyan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changyan Yu. The network helps show where Changyan Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Changyan Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 53 | |
| 2 | 2022 | 42 | |
| 3 | 2022 | 34 | |
| 4 | 2023 | 24 | |
| 5 | 2020 | 22 | |
| 6 | Synergistic activity of magnolin combined with B-RAF inhibitor SB590885 in hepatocellular carcinoma cells via targeting PI3K-AKT/mTOR and ERK MAPK pathway. | 2019 | 21 |
| 7 | 2022 | 20 | |
| 8 | 2022 | 19 | |
| 9 | 2023 | 17 | |
| 10 | 2023 | 17 | |
| 11 | 2024 | 13 | |
| 12 | 2023 | 12 | |
| 13 | 2023 | 10 | |
| 14 | 2024 | 9 | |
| 15 | 2024 | 9 | |
| 16 | 2024 | 7 | |
| 17 | 2019 | 6 | |
| 18 | [Research on olaquindox induced endoplasmic reticulum stress related apoptosis on nephrotoxicity]. | 2015 | 5 |
| 19 | 2024 | 5 | |
| 20 | 2024 | 5 |
About Changyan Yu
Changyan Yu is a scholar working on Aging, Molecular Biology, Endocrine and Autonomic Systems, Organic Chemistry and Toxicology, having authored 25 papers that have together received 362 indexed citations. Recurring topics across this work include Genetics, Aging, and Longevity in Model Organisms (12 papers), Circadian rhythm and melatonin (4 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Dietary Effects on Health (2 papers), Natural product bioactivities and synthesis (2 papers), Epigenetics and DNA Methylation (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Aging (122 citations), Geriatrics and Gerontology (15 citations), Endocrine and Autonomic Systems (25 citations), Complementary and alternative medicine (28 citations) and Cell Biology (56 citations). Changyan Yu has collaborated with scholars based in China. Frequent co-authors include Yi Xiao, Sanhua Li, Yun Liu, Nian Jiang, Xinting Zhu, Fang Liu, Changwei Song, Lingjie Meng, Haijuan Wang and Ying� Qin. Their work appears in journals such as International Immunopharmacology, iScience, European Journal of Pharmacology, Infection and Immunity and Reproductive Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.